Recommended Guidelines for Developing, Qualifying, and Implementing Complex In Vitro Models (CIVMs) for Drug Discovery
Open accessThe DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Abstract
The pharmaceutical industry is continuing to face high research and development (R&D) costs and low overall success rates of clinical compounds during drug development. There is an increasing demand for development and validation of healthy or disease-relevant and physiological human cellular models that can be implemented in early-stage discovery, thereby shifting attrition of future therapeutics to a point in discovery at which the costs are significantly lower. There needs to be a paradigm shift in the early drug discovery phase (which is lengthy and costly), away from simplistic cellular models that show an inability to effectively and efficiently reproduce healthy or human disease-relevant states to steer target and compound selection for safety, pharmacology, and efficacy questions. This perspective article covers the various stages of early drug discovery from target identification (ID) and validation to the hit/lead discovery phase, lead optimization, and preclinical safety. We outline key aspects that should be considered when developing, qualifying, and implementing complex in vitro models (CIVMs) during these phases, because criteria such as cell types (e.g., cell lines, primary cells, stem cells, and tissue), platform (e.g., spheroids, scaffolds or hydrogels, organoids, microphysiological systems, and bioprinting), throughput, automation, and single and multiplexing endpoints will vary. The article emphasizes the need to adequately qualify these CIVMs such that they are suitable for various applications (e.g., context of use) of drug discovery and translational research. The article ends looking to the future, in which there is an increase in combining computational modeling, artificial intelligence and machine learning (AI/ML), and CIVMs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Most OoCs developed in an academic setting are not designed with qualification in mind, causing a large gap between the development and qualification of models (Ekert et al., 2020).”
From Considering future qualification for regulatory science in the early development of microphysiological systems: a case study of microthrombosis in a Vessel-on-Chip (2024) · cites this paper as Ekert et al., 2020
Citations
Cites
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Machine Learning Applications in Cancer Prognosis and Prediction
Kourou, K., Exarchos, T. P., Exarchos, K. P., Karamouzis, M. V., & Fotiadis, D. I. (2015) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2014.11.005 · Cited by 3,338
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
Clinical development success rates for investigational drugs
Hay, M., Thomas, D. W., Craighead, J. L., Economides, C., & Rosenthal, J. (2014) · Nature Biotechnology · doi:10.1038/nbt.2786 · Cited by 2,536 · cited 3×
“To achieve this stepwise change, it is time to stop using (1) poorly defined cellular models for target identification, (2) nonrelevant cell-based screening or LO assays with immortalized cell lines, and (3) in vivo models that have shown low predictive value or translational relevance (Fig.”
BackgroundMethodProspective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients
van de Wetering, M., Francies, H. E., Francis, J. M., Bounova, G., Iorio, F., Pronk, A., van Houdt, W., van Gorp, J., Taylor-Weiner, A., Kester, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.03.053 · Cited by 2,408
Self-citationThe support of human genetic evidence for approved drug indications
Nelson, M. R., Tipney, H., Painter, J. L., Shen, J., Nicoletti, P., Shen, Y., Floratos, A., Sham, P. C., Li, M. J., Wang, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3314 · Cited by 1,666 · cited 2×
“To achieve this stepwise change, it is time to stop using (1) poorly defined cellular models for target identification, (2) nonrelevant cell-based screening or LO assays with immortalized cell lines, and (3) in vivo models that have shown low predictive value or translational relevance (Fig.”
MethodSchwank, G., Koo, B.-K., Sasselli, V., Dekkers, J. F., Heo, I., Demircan, T., Sasaki, N., Boymans, S., Cuppen, E., van der Ent, C. K., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.11.002 · Cited by 1,424
Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids
Matano, M., Date, S., Shimokawa, M., Takano, A., Fujii, M., Ohta, Y., Watanabe, T., Kanai, T., & Sato, T. (2015) · Nature Medicine · doi:10.1038/nm.3802 · Cited by 1,135
Sequential cancer mutations in cultured human intestinal stem cells
Drost, J., van Jaarsveld, R. H., Ponsioen, B., Zimberlin, C., van Boxtel, R., Buijs, A., Sachs, N., Overmeer, R. M., Offerhaus, G. J., Begthel, H., et al. (2015) · Nature · doi:10.1038/nature14415 · Cited by 1,067
Tales from the crypt: new insights into intestinal stem cells
Gehart, H., & Clevers, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0081-y · Cited by 1,005
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Dekkers, J. F., Wiegerinck, C. L., de Jonge, H. R., Bronsveld, I., Janssens, H. M., de Winter-de Groot, K. M., Brandsma, A. M., de Jong, N. W. M., Bijvelds, M. J. C., Scholte, B. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3201 · Cited by 999
A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993 · cited 1×
“25(10) 1174 –1190 © 2020 Society for Laboratory Automation and Screening DOI: 10.”
BackgroundKim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Reprogramming human T cell function and specificity with non-viral genome targeting
Roth, T. L., Puig-Saus, C., Yu, R., Shifrut, E., Carnevale, J., Li, P. J., Hiatt, J., Saco, J., Krystofinski, P., Li, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0326-5 · Cited by 839
In vitro generation of human pluripotent stem cell derived lung organoids
Dye, B. R., Hill, D. R., Ferguson, M. A., Tsai, Y.-H., Nagy, M. S., Dyal, R., Wells, J. M., Mayhew, C. N., Nattiv, R., Klein, O. D., et al. (2015) · eLife · doi:10.7554/elife.05098 · Cited by 819
Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro
Benam, K. H., Villenave, R., Lucchesi, C., Varone, A., Hubeau, C., Lee, H.-H., Alves, S. E., Salmon, M., Ferrante, T. C., Weaver, J. C., et al. (2016) · Nature Methods · doi:10.1038/nmeth.3697 · Cited by 816
The use of 3-d cultures for high-throughput screening: the multicellular spheroid model.
Kunz-Schughart, L. A., Freyer, J. P., Hofstaedter, F., & Ebner, R. (2004) · SLAS DISCOVERY · doi:10.1177/1087057104265040 · Cited by 797
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739
Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation
Jeon, J. S., Bersini, S., Gilardi, M., Dubini, G., Charest, J. L., Moretti, M., & Kamm, R. D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417115112 · Cited by 723
Takasato, M., Er, P. X., Becroft, M., Vanslambrouck, J. M., Stanley, E. G., Elefanty, A. G., & Little, M. H. (2014) · Nature Cell Biology · doi:10.1038/ncb2894 · Cited by 720
Virtual Screening Strategies in Drug Discovery: A Critical Review
Lavecchia, A., & Giovanni, C. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990001 · Cited by 686
Induced pluripotent stem cells in disease modelling and drug discovery
Rowe, R. G., & Daley, G. Q. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0100-z · Cited by 670
In Silico Labeling: Predicting Fluorescent Labels in Unlabeled Images
Christiansen, E. M., Yang, S. J., Ando, D. M., Javaherian, A., Skibinski, G., Lipnick, S., Mount, E., O’Neil, A., Shah, K., Lee, A. K., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.040 · Cited by 635
3D bioprinting of tissues and organs for regenerative medicine
Vijayavenkataraman, S., Yan, W.-C., Lu, W. F., Wang, C.-H., & Fuh, J. Y. H. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.004 · Cited by 630
O’Brien, P. J., Irwin, W., Diaz, D., Howard-Cofield, E., Krejsa, C. M., Slaughter, M. R., Gao, B., Kaludercic, N., Angeline, A., Bernardi, P., et al. (2006) · Archives of Toxicology · doi:10.1007/s00204-006-0091-3 · Cited by 609
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., & Rizzi, S. C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.064 · Cited by 602
How artificial intelligence is changing drug discovery
Fleming, N. (2018) · Nature · doi:10.1038/d41586-018-05267-x · Cited by 546
Advances in 3D cell culture technologies enabling tissue‐like structures to be created in vitro
Knight, E., & Przyborski, S. (2015) · Journal of Anatomy · doi:10.1111/joa.12257 · Cited by 530
Microfluidic 3D cell culture: from tools to tissue models
van Duinen, V., Trietsch, S. J., Joore, J., Vulto, P., & Hankemeier, T. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.05.002 · Cited by 500
Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
Edington, C. D., Chen, W. L. K., Geishecker, E., Kassis, T., Soenksen, L. R., Bhushan, B. M., Freake, D., Kirschner, J., Maass, C., Tsamandouras, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22749-0 · Cited by 487
Guidelines for the use of cell lines in biomedical research
Geraghty, R. J., Capes-Davis, A., Davis, J. M., Downward, J., Freshney, R. I., Knezevic, I., Lovell-Badge, R., Masters, J. R. W., Meredith, J., Stacey, G. N., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.166 · Cited by 464
Drost, J., van Boxtel, R., Blokzijl, F., Mizutani, T., Sasaki, N., Sasselli, V., de Ligt, J., Behjati, S., Grolleman, J. E., van Wezel, T., et al. (2017) · Science · doi:10.1126/science.aao3130 · Cited by 461
Impact of a five-dimensional framework on R&D productivity at AstraZeneca
Morgan, P., Brown, D. G., Lennard, S., Anderton, M. J., Barrett, J. C., Eriksson, U., Fidock, M., Hamrén, B., Johnson, A., March, R. E., et al. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.244 · Cited by 452 · cited 3×
“To achieve this stepwise change, it is time to stop using (1) poorly defined cellular models for target identification, (2) nonrelevant cell-based screening or LO assays with immortalized cell lines, and (3) in vivo models that have shown low predictive value or translational relevance (Fig.”
BackgroundMethodDeep Learning in Label-free Cell Classification
Chen, C. L., Mahjoubfar, A., Tai, L.-C., Blaby, I. K., Huang, A., Niazi, K. R., & Jalali, B. (2016) · Scientific Reports · doi:10.1038/srep21471 · Cited by 443
Nguyen, D. G., Funk, J., Robbins, J. B., Crogan-Grundy, C., Presnell, S. C., Singer, T., & Roth, A. B. (2016) · PLOS ONE · doi:10.1371/journal.pone.0158674 · Cited by 379
Seki, A., & Rutz, S. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171626 · Cited by 372
Korotcov, A., Tkachenko, V., Russo, D. P., & Ekins, S. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00578 · Cited by 352
Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury
Proctor, W. R., Foster, A. J., Vogt, J., Summers, C., Middleton, B., Pilling, M. A., Shienson, D., Kijanska, M., Ströbel, S., Kelm, J. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2002-1 · Cited by 328 · cited 1×
“To perform genome-editing studies, capabilities in robust cellular models require extensive analysis of gene expression in human tissue [laser capture microdissection (LCM), single-cell technologies, spatial transcriptomics, and proteomics] to enable (1) data-driven decisions on cell model relevance, (2) expansive mul…”
MethodBell, C. C., Dankers, A. C. A., Lauschke, V. M., Sison-Young, R., Jenkins, R., Rowe, C., Goldring, C. E., Park, K., Regan, S. L., Walker, T., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfx289 · Cited by 327
Self-citationA vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications
Phan, D. T. T., Wang, X., Craver, B. M., Sobrino, A., Zhao, D., Chen, J. C., Lee, L. Y. N., George, S. C., Lee, A. P., & Hughes, C. C. W. (2017) · Lab on a Chip · doi:10.1039/c6lc01422d · Cited by 325
Majumder, B., Baraneedharan, U., Thiyagarajan, S., Radhakrishnan, P., Narasimhan, H., Dhandapani, M., Brijwani, N., Pinto, D. D., Prasath, A., Shanthappa, B. U., et al. (2015) · Nature Communications · doi:10.1038/ncomms7169 · Cited by 308
Myungjin Lee, J., Mhawech-Fauceglia, P., Lee, N., Cristina Parsanian, L., Gail Lin, Y., Andrew Gayther, S., & Lawrenson, K. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.41 · Cited by 301
Marx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
When Quality Beats Quantity: Decision Theory, Drug Discovery, and the Reproducibility Crisis
Scannell, J. W., & Bosley, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0147215 · Cited by 279
Bauer, S., Wennberg Huldt, C., Kanebratt, K. P., Durieux, I., Gunne, D., Andersson, S., Ewart, L., Haynes, W. G., Maschmeyer, I., Winter, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14815-w · Cited by 272
Droplet Microarrays: From Surface Patterning to High‐Throughput Applications
Feng, W., Ueda, E., & Levkin, P. A. (2018) · Advanced Materials · doi:10.1002/adma.201706111 · Cited by 246
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection
Ortega-Prieto, A. M., Skelton, J. K., Wai, S. N., Large, E., Lussignol, M., Vizcay-Barrena, G., Hughes, D., Fleck, R. A., Thursz, M., Catanese, M. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02969-8 · Cited by 236
In silico ADME-Tox modeling: progress and prospects
Alqahtani, S. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1389897 · Cited by 231
Microfluidics: A New Tool for Modeling Cancer–Immune Interactions
Boussommier-Calleja, A., Li, R., Chen, M. B., Wong, S. C., & Kamm, R. D. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2015.12.003 · Cited by 224
Duodenum Intestine-Chip for preclinical drug assessment in a human relevant model
Kasendra, M., Luc, R., Yin, J., Manatakis, D. V., Kulkarni, G., Lucchesi, C., Sliz, J., Apostolou, A., Sunuwar, L., Obrigewitch, J., et al. (2020) · eLife · doi:10.7554/elife.50135 · Cited by 222
Tsamandouras, N., Chen, W. L. K., Edington, C. D., Stokes, C. L., Griffith, L. G., & Cirit, M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0122-4 · Cited by 222
Engineering Microfluidic Organoid-on-a-Chip Platforms
Yu, F., Hunziker, W., & Choudhury, D. (2019) · Micromachines · doi:10.3390/mi10030165 · Cited by 218
State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology
Alépée, N. (2014) · ALTEX · doi:10.14573/altex.1406111 · Cited by 217
Jabs, J., Zickgraf, F. M., Park, J., Wagner, S., Jiang, X., Jechow, K., Kleinheinz, K., Toprak, U. H., Schneider, M. A., Meister, M., et al. (2017) · Molecular Systems Biology · doi:10.15252/msb.20177697 · Cited by 202
3D Bioprinting: A Novel Avenue for Manufacturing Tissues and Organs
Zhang, B., Gao, L., Ma, L., Luo, Y., Yang, H., & Cui, Z. (2019) · Engineering · doi:10.1016/j.eng.2019.03.009 · Cited by 195
Quantitative nature of overexpression experiments
Moriya, H. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-07-0512 · Cited by 172
Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2016) · BMC Medicine · doi:10.1186/s12916-016-0735-y · Cited by 171
Ekert, J. E., Johnson, K., Strake, B., Pardinas, J., Jarantow, S., Perkinson, R., & Colter, D. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092248 · Cited by 165
Self-citationBolognin, S., Fossépré, M., Qing, X., Jarazo, J., Ščančar, J., Moreno, E. L., Nickels, S. L., Wasner, K., Ouzren, N., Walter, J., et al. (2019) · Advanced Science · doi:10.1002/advs.201800927 · Cited by 146
Boehnke, K., Iversen, P. W., Schumacher, D., Lallena, M. J., Haro, R., Amat, J., Haybaeck, J., Liebs, S., Lange, M., Schäfer, R., et al. (2016) · SLAS Discovery · doi:10.1177/1087057116650965 · Cited by 144
Modeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids
Fujii, M., Clevers, H., & Sato, T. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.048 · Cited by 140
Barrile, R., van der Meer, A. D., Park, H., Fraser, J. P., Simic, D., Teng, F., Conegliano, D., Nguyen, J., Jain, A., Zhou, M., et al. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1054 · Cited by 138
FutureTox II: In vitro Data and In Silico Models for Predictive Toxicology
Knudsen, T. B., Keller, D. A., Sander, M., Carney, E. W., Doerrer, N. G., Eaton, D. L., Fitzpatrick, S. C., Hastings, K. L., Mendrick, D. L., Tice, R. R., et al. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfu234 · Cited by 132
Pastuła, A., Middelhoff, M., Brandtner, A., Tobiasch, M., Höhl, B., Nuber, A. H., Demir, I. E., Neupert, S., Kollmann, P., Mazzuoli-Weber, G., et al. (2016) · Stem Cells International · doi:10.1155/2016/3710836 · Cited by 129
Howes, A. L., Richardson, R. D., Finlay, D., & Vuori, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108283 · Cited by 121
Concerns, challenges and promises of high-content analysis of 3D cellular models
Carragher, N. O., Piccinini, F., Tesei, A., Trask, O. J., Bickle, M., & Horváth, P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.99 · Cited by 94
Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective
Ewart, L., Fabre, K., Chakilam, A., Dragan, Y., Duignan, D. B., Eswaraka, J., Gan, J., Guzzie-Peck, P., Otieno, M., Jeong, C. G., et al. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217715441 · Cited by 89
Self-citationMaass, C., Stokes, C. L., Griffith, L. G., & Cirit, M. (2017) · Integrative Biology · doi:10.1039/c6ib00243a · Cited by 72
A 1536-Well 3D Viability Assay to Assess the Cytotoxic Effect of Drugs on Spheroids
Madoux, F., Tanner, A., Vessels, M., Willetts, L., Hou, S., Scampavia, L., & Spicer, T. P. (2017) · SLAS Discovery · doi:10.1177/2472555216686308 · Cited by 72
Barrier responses of human bronchial epithelial cells to grass pollen exposure
Blume, C., Swindle, E. J., Dennison, P., Jayasekera, N. P., Dudley, S., Monk, P., Behrendt, H., Schmidt-Weber, C. B., Holgate, S. T., Howarth, P. H., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00075612 · Cited by 70
Maximizing the impact of microphysiological systems with in vitro–in vivo translation
Cirit, M., & Stokes, C. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00039e · Cited by 70
Blume, C., Reale, R., Held, M., Loxham, M., Millar, T. M., Collins, J. E., Swindle, E. J., Morgan, H., & Davies, D. E. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.139 · Cited by 59
Microfluidic-Based Multi-Organ Platforms for Drug Discovery
Rezaei Kolahchi, A., Khadem Mohtaram, N., Pezeshgi Modarres, H., Mohammadi, M., Geraili, A., Jafari, P., Akbari, M., & Sanati-Nezhad, A. (2016) · Micromachines · doi:10.3390/mi7090162 · Cited by 53
Yu, J., Cilfone, N., Large, E., Sarkar, U., Wishnok, J., Tannenbaum, Sr., Hughes, D., Lauffenburger, D., Griffith, L., Stokes, C., et al. (2015) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12010 · Cited by 52
Norris, J. L., Farrow, M. A., Gutierrez, D. B., Palmer, L. D., Muszynski, N. D., Sherrod, S. D., Pino, J. C., Allen, J. L., Spraggins, J. M., Lubbock, A. L. R., et al. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b01004 · Cited by 46
Hassell, B. A., Goyal, G., Lee, E., Sontheimer-Phelps, A., Levy, O., Chen, C. S., & Ingber, D. E. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.028 · Cited by 44
CELLector: Genomics-Guided Selection of Cancer In Vitro Models
Najgebauer, H., Yang, M., Francies, H. E., Pacini, C., Stronach, E. A., Garnett, M. J., Saez-Rodriguez, J., & Iorio, F. (2020) · Cell Systems · doi:10.1016/j.cels.2020.04.007 · Cited by 43
Kota, S., Hou, S., Guerrant, W., Madoux, F., Troutman, S. A., Fernández-Vega, V., Alekseeva, N., Madala, N., Scampavia, L. D., Kissil, J. L., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0257-5 · Cited by 36
Shin, W., & Kim, H. J. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.05.006 · Cited by 31
Rowntree, R. K., & McNeish, J. D. (2010) · Regenerative Medicine · doi:10.2217/rme.10.36 · Cited by 29
Cytopathological image analysis using deep-learning networks in microfluidic microscopy
Gopakumar, G., Babu, K. H., Mishra, D., Gorthi, S. S., & Subrahmanyam, G. R. K. S. (2016) · Journal of the Optical Society of America A · doi:10.1364/josaa.34.000111 · Cited by 28
Translatability score revisited: differentiation for distinct disease areas
Wendler, A., & Wehling, M. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1329-y · Cited by 16
Microfluidic Cell Culture Systems
(2018) · Elsevier eBooks · doi:10.1016/c2016-0-05054-4 · Cited by 15
Modeling Liver Biology and the Tissue Response to Injury in Bioprinted Human Liver Tissues
Retting, K. N., Carter, D., Crogan‐Grundy, C., Khatiwala, C. B., Norona, L. M., Paffenroth, E. H., Hanumegowda, U., Chen, A. P., Hazelwood, L. A., Lehman‐McKeeman, L. D., et al. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2018.0015 · Cited by 14
Jeong, C. G., Negro, G. D., Getsios, S., & Ekert, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813671-3.00005-0 · Cited by 13
Self-citationCross-Talk between Epithelial Cells and Type 2 Immune Signaling: The Role of IL-25
Gordon, E. D., Locksley, R. M., & Fahy, J. V. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201512-2534ed · Cited by 12
CELLector: Genomics Guided Selection of Cancer in vitro ModelsPreprint
Najgebauer, H., Yang, M., Francies, H. E., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/275032 · Cited by 10
Cited by
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology
Ewart, L., Apostolou, A., Briggs, S. A., Carman, C. V., Chaff, J. T., Heng, A. R., Jadalannagari, S., Janardhanan, J., Jang, K.-J., Joshipura, S. R., et al. (2022) · Communications Medicine · doi:10.1038/s43856-022-00209-1 · Cited by 337
Daly, A. C., Prendergast, M. E., Hughes, A. J., & Burdick, J. A. (2021) · Cell · doi:10.1016/j.cell.2020.12.002 · Cited by 332
Seal, S., Mahale, M., García-Ortegón, M., Joshi, C. K., Hosseini-Gerami, L., Beatson, A., Greenig, M., Shekhar, M., Patra, A., Weis, C., et al. (2025) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5c00033 · Cited by 183
Predictive validity in drug discovery: what it is, why it matters and how to improve it
Scannell, J. W., Bosley, J., Hickman, J. A., Dawson, G. R., Truebel, H., Ferreira, G. S., Richards, D. B., & Treherne, J. M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00552-x · Cited by 142
Metadata
- Authors
- Ekert, J. E., Deakyne, J., Pribul-Allen, P., Terry, R., Schofield, C., Jeong, C. G., Storey, J., Mohamet, L., Francis, J., Naidoo, A., Amador, A., Klein, J.-L., & Rowan, W.
- Affiliations
- GlaxoSmithKline (United States) (US)
- GlaxoSmithKline (United Kingdom) (GB)
- insitro, inc. (United States) (US)
- Corresponding author
- Ekert, Jason E.
- Venue
- SLAS DISCOVERY
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 25
- Issue
- 10
- Pages
- 1174-1190
- ISSN
- 2472-5552 (ISSN-L)
- OpenAlex
- W3030677830
- Cited by
- 68
- References
- 89
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 12 · 2023: 9 · 2022: 9 · 2021: 12
- FWCI
- 0.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 476 d)
- Locations
- SLAS DISCOVERY (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- early drug discovery, model qualification, organoids, spheroids, microphysiological systems, bioprinting, stem cells, primary cells, lead optimization, preclinical safety, target identification and validation, computational modeling, artificial intelligence in drug discovery, translational research
- MeSH terms
- Machine Learning, Drug Development, Animals, Artificial Intelligence, Automation, Drug Evaluation, Preclinical, Humans, Models, Molecular, Research, Guidelines as Topic, Drug Discovery, High-Throughput Screening Assays, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.